Brief: Eckert & Ziegler Forecast For 2023 Remains Unchanged
Aug 10 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG EUZG.DE :
* FORECAST FOR FINANCIAL YEAR 2023 PUBLISHED ON MARCH 30,
2023
REMAINS UNCHANGED
* INCREASED ITS SALES BY 10% TO EUR 118.0 MILLION IN FIRST
HALF OF
2023.
* H1 NET INCOME WAS EUR 3.5 MILLION OR 25% LOWER THAN IN
SAME
PERIOD LAST YEAR
* H1 EBIT 19.5 MILLION EUR, -17%
* H1 EBITDA 25.6 MILLION EUR, -10%
Further company coverage: EUZG.DE
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587720920;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth